Axolot Solutions has signed a trial agreement with a customer in the biogas industry

Report this content

Axolot Solutions Finland Oy has signed an agreement with a customer in the biogas industry for trials with Axolot’s patented technology.

The trials will be carried out at the customer’s site in Finland, with the purpose of purifying their reject water arising from dewatering of digestate, being a residual from biogas production. The reject water should be cleaned from solids and nutrients.

Sirkku Rönkä, Managing Director of Axolot Solutions in Finland says: “This trial order is our third in the biogas industry within a short time frame – a good proof of the trust biogas companies have in the abilities of our AxoPur® technology. With the help of our technology we hope to provide a method for handling biogas digestate more efficiently and support biogas production as a green technology." The trials will be carried out during February.

For further information, please contact:
Martin Ragnar, President and CEO Axolot Solutions, tel: +46 70 817 11 16, mail: martin.ragnar@axolotsolutions.com
 
  

About Axolot Solutions

Axolot Solutions is a Swedish environmental technology company, providing systems for industrial water purification. The company offers a holistic solution based upon a proprietary technology within electro-coagulation and flotation. Axolot's water purification concept is cost efficient and enables recirculation of the water. This leads to a reduced environmental footprint. Axolot Solutions also has business activities in Finland, through its affiliated company Axolot Solutions Finland Oy. More information about the Company and its business activities can be found at www.axolotsolutions.com.

Axolot Solutions Holding AB is based in Helsingborg, Sweden, and its shares (ticker: Axolot) are listed at Nasdaq First North Growth Market, Stockholm, since November 21, 2018. FNCA Sweden AB is the Certified Adviser of Axolot Solutions. FNCA Sweden AB can be reached at info@fnca.se and on tel +46 8 528 003 99.